Study of STX-1150 for high cholesterol
Part of Heart & circulation, Hormones & metabolism clinical trials.
This early-phase trial tests a new medication called STX-1150 for people with high LDL cholesterol. It aims to see if the drug is safe and how well it works to lower cholesterol.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have high LDL cholesterol (bad cholesterol), even if you're already taking medication for it.
- You are willing to follow the study procedures and give written permission (consent) to participate.
- You have NOT had a heart attack, stroke, or similar event in the last 6 months.
- You do NOT have any other serious or uncontrolled medical condition that could interfere with the study.
- You do NOT have a genetic condition called familial hypercholesterolemia.
- You do NOT have active or past liver disease, and you have not taken certain cholesterol-lowering drugs (like PCSK9 inhibitors) recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injectable medication called HST101 for lowering cholesterol in people who are already taking cholesterol pills but still have high levels. It may help if you have heart disease or are at high risk.
This study tests an experimental drug (QLC7401) that may help lower LDL ('bad') cholesterol in people who already have high cholesterol or mixed hyperlipidemia. If you're on stable cholesterol medication but still need more lowering, this trial could offer another option.
This trial tests a new medicine, CTX310, for people with persistently high levels of fats (triglycerides) and cholesterol that have not improved with standard treatments. It aims to see if the drug is safe and tolerable.
This study tests a new drug, HST101, to see if it is safe for healthy Chinese people with high cholesterol. It is an early-phase trial, so it focuses on safety first.
This trial tests a new medicine that aims to lower LDL (bad) cholesterol in healthy adults. It will help doctors understand how the medicine works in the body and how safe it is.
This study tests a new investigational medicine (QLC7401) that aims to lower LDL ('bad') cholesterol when added to your current cholesterol-lowering therapy. If you are already on a statin but your cholesterol is still not low enough, this trial might help you reach your goals.
Hear when a new Elevated LDL-C and High Cholesterol trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.